osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Genes Dev. 1998 May 1;12(9):1260-8. doi: 10.1101/gad.12.9.1260.

Abstract

Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG-/- mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly, OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.

MeSH terms

  • Animals
  • Arteries / pathology
  • Bone Density / genetics
  • Bone Density / physiology
  • Calcinosis / etiology*
  • Calcinosis / pathology
  • Disease Models, Animal
  • Female
  • Gene Targeting
  • Glycoproteins / deficiency*
  • Glycoproteins / genetics
  • Glycoproteins / physiology
  • In Situ Hybridization
  • Male
  • Mice
  • Mice, Knockout
  • Osteoporosis / etiology*
  • Osteoporosis / pathology
  • Osteoprotegerin
  • Receptors, Cytoplasmic and Nuclear*
  • Receptors, Tumor Necrosis Factor
  • Vascular Diseases / etiology*
  • Vascular Diseases / pathology

Substances

  • Glycoproteins
  • Osteoprotegerin
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • Tnfrsf11b protein, mouse